You are here:

Healthcare & Life Sciences

The rapid-changing regulatory environment and the specific needs for protection and commercialization of the key business assets in the healthcare & life sciences sector call for comprehensive advice based on extensive expertise. We have made it our mission to deliver you with inspiring solutions to tackle your challenges and allow your business to thrive.

Our clients range from med-tech and bio-tech companies, all the way to pharmaceutical leaders, investors, suppliers, cure and care institutions, insurers, governmental bodies and healthcare real estate developers.

Full range of services

Our full-service offer integrates a regulatory, legal and tax approach, with a particular focus on:

  • Private and public M&A, including private equity;
  • Equity and debt financing;
  • Joint-ventures and collaborations, including R&D;
  • Protection and commercialization of intellectual property assets;
  • Contracts related to development, manufacturing and distribution of regulated products;
  • Regulatory requirements, authorizations and proceedings;
  • Employment, general corporate governance and restructurings;
  • Swiss and international direct tax and VAT.

Advice beyond borders

Our global dedicated healthcare & life sciences team consists of 40 attorneys at law and tax advisors working together to provide leading expertise across a wide range of disciplines. We bring together expertise in commercial, corporate, tax, regulatory, intellectual property, competition, data protection, and employment matters. Combined with monitoring market developments, this allows us to provide advice in a proactive and pragmatic manner, enabling you to capitalize on business opportunities.

Local knowledge in our home jurisdictions and the EU combined with cross-border expertise: that is what we can offer you to ensure first-class advice.

What you can expect

  • In-depth knowledge of the sector, your business model, and future developments;
  • Creative answers and solutions from a tight-knit team;
  • Pragmatic, clear, concise and well-thought-out advice;
  • Responsive service with short delivery time frames;
  • Competitive fees based on our extensive track record and specialization; and
  • A strong commitment to a mutually beneficial long-term partnership.
The Belgian ‘Cayman tax’ and its impact on wealth and estate planning in Belgium
Deal - 26 July 2018 - Switzerland

Acquisition of Takeda Chromo by Shanghai Pharmaceuticals

Loyens & Loeff advised Shanghai Pharmaceuticals Holding Co. on the acquisition of Takeda Chromo Beteiligungs AG.
read more
Deal - 02 May 2018 - Switzerland

Joint venture 12 Horizons and SIX Swiss Exchange

Loyens & Loeff advised 12 Horizons and its shareholders on joint venture with SIX Swiss Exchange.
read more
Belgian Fairness Tax partially violates EU law
Deal - 30 April 2018 - Switzerland

Acquisition of full ownership of Patrón by Bacardi

Loyens & Loeff advised Bacardi on the acquisition of the full ownership of Patrón Spirits.
read more
Belgian Constitutional Court decides on Fairness Tax
Deal - 24 April 2018 - Switzerland

Launch of operations of Change Up in Switzerland

Loyens & Loeff advised Touchcorp on the launch of the “Change Up” app.
read more
  1. previous
  2. 1
  3. 2